US FDA to address challenges to medtech innovation at 15 March public workshop
This article was originally published in SRA
Executive Summary
The public meeting at which the US Food and Drug Administration plans to solicit feedback on certain actions proposed in its initiative on accelerating the development and regulatory evaluation of innovative medical devices is set to take place tomorrow1,2.